Hims & Hers Health Inc. ($HIMS) Stock Forecast: Up 5.0% Today

What is Hims & Hers Health Inc.?

HIMS Stock Assessment:

Why is Hims & Hers Health Inc. going up?

HIMS stock is up 5.0% on Aug 26, 2025 19:45

• Hims & Hers Health, Inc. (NYSE: HIMS) is a company specializing in telehealth and wellness products, addressing various health and personal care needs. The stock showed strong bullish movement today.
• Possible factors like class action lawsuits and short interest could have initially led to uncertainty and volatility in HIMS.
• However, the market sentiment changed as investors possibly identified a short squeeze opportunity, resulting in increased buying pressure and a rise in the stock price.
• The upcoming lead plaintiff deadline and shareholder alerts might have spurred urgency among investors, contributing to the positive momentum in the stock.
• Overall, the blend of short squeeze potential and legal developments likely propelled the bullish movement in HIMS stock today.

HIMS Price Chart

HIMS Technical Analysis

HIMS News

Hims & Hers Health, Inc. Class Action: Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 - HIMS - Hims & Hers Health ( NYSE:HIMS )

NEW YORK, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ( "Hims & Hers Health, Inc." or the "Company" ) HIMS of a class action securities lawsuit.

https://www.benzinga.com/pressreleases/25/08/g47320965/hims-hers-health-inc-class-action-levi-korsinsky-reminds-hims-hers-health-inc-investors-of-the-pen

Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire - Hims & Hers Health ( NYSE:HIMS ) , Oscar Health ( NYSE:OSCR ) , Rocket Companies ( NYSE:RKT )

Rocket, Oscar, and Hims boast sky-high short interest-making them prime tinder for a squeeze spark. With thin days-to-cover, shorts could flip fast from confident bets to panic-fueled fire drills. The market is reacting to Powell's speech. Learn how to time your next move. Details here →

https://www.benzinga.com/trading-ideas/short-ideas/25/08/47316765/rocket-oscar-hims-hers-short-sellers-are-playing-with-fire

Rocket, Oscar, Hims & Hers: Short Sellers Are Playing With Fire - Hims & Hers Health ( NYSE:HIMS ) , Oscar Health ( NYSE:OSCR ) , Rocket Companies ( NYSE:RKT )

Rocket, Oscar, and Hims boast sky-high short interest-making them prime tinder for a squeeze spark. With thin days-to-cover, shorts could flip fast from confident bets to panic-fueled fire drills. See the seasonal trading strategy that's beating the S&P 500 by 6X this year. Details here →

https://www.benzinga.com/short-sellers/25/08/47316765/rocket-oscar-hims-hers-short-sellers-are-playing-with-fire

HIMS & HERS HEALTH SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Hims & Hers Health, Inc. - HIMS - Hims & Hers Health ( NYSE:HIMS )

NEW ORLEANS, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until August 25, 2025 to file lead plaintiff applications in securities class action lawsuits against Hims & Hers Health, Inc. ( "Hims" or the "Company" ) HIMS, ...

https://www.benzinga.com/pressreleases/25/08/g47250035/hims-hers-health-shareholder-alert-claimsfiler-reminds-investors-with-losses-in-excess-of-100-000-

Trending Today

Mantle ($MNT) Crypto Forecast: Up 5.8% Today

Avalanche ($AVAX) Crypto Forecast: Down 5.0% Today

Sonic (prev. FTM) ($S) Crypto Forecast: Down 5.3% Today

Jupiter ($JUP) Crypto Forecast: Down 7.6% Today

Sei ($SEI) Crypto Forecast: Down 5.6% Today

Pepe ($PEPE) Crypto Forecast: Down 7.6% Today

Monero ($XMR) Crypto Forecast: Up 6.2% Today

Shiba Inu ($SHIB) Crypto Forecast: Down 7.0% Today

Sui ($SUI) Crypto Forecast: Down 6.1% Today

Chainlink ($LINK) Crypto Forecast: Down 5.1% Today

Hims & Hers Health Inc. Price History

01.07.2025 - HIMS Stock was down 8.3%

• The bearish movement in HIMS stock today could be attributed to the class action lawsuit notification, which might have caused uncertainty and negative sentiment among investors.
• Despite the bullish stance taken by whales in the market, the looming legal issues and uncertainties surrounding the company's stock could have overshadowed the positive investor sentiment.
• The stock's fluctuation could also be influenced by the overall market trend, with weight-loss giants stumbling and potentially impacting the telehealth sector's performance.
• HIMS reaching near all-time highs earlier in the day might have triggered profit-taking by some investors, leading to the bearish movement observed.

01.07.2025 - HIMS Stock was down 8.2%

• Despite positive developments regarding the company's growth and healthcare innovations, HIMS stock displayed bearish movement today.
• Ongoing class action lawsuits against Hims & Hers Health, Inc. could be a contributing factor to the market's bearish reaction, causing uncertainty among investors.
• HIMS had been benefiting from consistent product demand and subscriber growth. However, the presence of legal challenges and uncertainties linked to the lawsuits may have cast a shadow over these favorable aspects, leading to the bearish market trend.
• The stock's performance could be adversely impacted by investor wariness surrounding the legal consequences and imminent deadlines associated with the class action lawsuits.

31.06.2025 - HIMS Stock was up 7.8%

• The class action lawsuit developments may have caused some initial uncertainty among investors. However, strong product demand and subscriber growth leading up to Q2 earnings are believed to have instilled confidence in the company's performance.
• The outperformance of HIMS in comparison to the wider market suggests that investors hold an optimistic outlook on the company's future, despite recent legal issues.
• Weakness in Novo Nordisk and a potential partnership with HIMS that did not materialize have underscored HIMS' relative strength and growth potential within the telehealth industry.
• Despite ongoing legal challenges and negative publicity surrounding the class action lawsuits, market sentiment appears to be more focused on the company's operational strength and potential for growth, driving the bullish movement in HIMS stock.

12.07.2025 - HIMS Stock was down 5.3%

• The bearish movement in HIMS stock today could be attributed to the company posting weaker than expected Q2 revenue, missing consensus estimates.
• Despite the miss in Q2 revenue, HIMS reiterated its 2025 revenue and adjusted EBITDA guidance, showing confidence in its long-term growth prospects.
• The market may be reacting to the near-term challenges highlighted by analysts, which could be contributing to the downward pressure on HIMS stock.
• HIMS' global expansion efforts with tech-integrated care and partnerships with ZAVA and semaglutide could be positive catalysts for the stock in the future, potentially offsetting today's bearish movement.

12.07.2025 - HIMS Stock was down 5.2%

• The Chief Executive Officer of Hims & Hers Health, Andrew Dudum, sold a significant amount of company stock, totaling $33.38 million. Insider selling of this magnitude could signal lack of confidence in the company's future prospects, leading to a negative sentiment among investors.
• The company's focus on redefining virtual care and expanding globally with integrated tech platforms could be seen as a positive long-term strategy. However, the immediate impact of the insider sell may have overshadowed these efforts, contributing to the bearish movement in the stock price.
• Investors may be interpreting the insider sell as a red flag, prompting them to sell off their positions in HIMS, driving the stock price down. This event underscores the importance of monitoring insider trading activities as they can provide valuable insights into a company's health and potential future performance.

19.07.2025 - HIMS Stock was down 5.4%

• HIMS announced new hormonal health offerings and international expansion plans, signaling long-term growth potential. However, concerns about high GLP-1 retention and rising costs impacting gross margins may have led to the negative market reaction.
• Shareholder investigations and class action lawsuits against HIMS could have contributed to the bearish sentiment, creating uncertainty among investors.
• The launch of leveraged ETFs for HIMS by Defiance ETFs might have added to the volatility in the stock, as leveraged ETFs can amplify market movements.
• Despite recording a subscriber surge and revenue growth in the second quarter, the stock plunged 21.3% in three months, prompting investors to evaluate whether to hold or exit, reflecting a mixed sentiment towards the company's future prospects.

19.07.2025 - HIMS Stock was down 5.4%

• HIMS stock dropped by 21.3% in the last three months despite a growth in subscribers and revenue during the second quarter of 2025. Concerns about increasing costs impacting gross margins are prevalent.
• Shareholder alerts and investigations by law firms suggest potential legal issues or investor concerns, affecting the stock negatively.
• The introduction of leveraged ETFs by Defiance ETFs for companies like HIMS may have influenced market movements due to increased volatility and speculative trading.
• Investors are encouraged to assess their options and rights amid an ongoing class action securities lawsuit and shareholder alerts associated with HIMS.

05.07.2025 - HIMS Stock was down 12.2%

• The downward movement in HIMS stock today can be attributed to the following factors:
• Weaker than expected Q2 revenue was reported, missing estimates, leading to a significant drop in the stock price.
• A class action lawsuit has been filed against the company and certain senior executives for potential violations of federal securities laws, which may have also contributed to investor concerns and selling pressure.
• Despite beating earnings estimates, the market sentiment towards HIMS was dampened by the revenue miss, causing a negative impact on the stock price.
• The company's near-term challenges, as highlighted by analysts, added to the downward pressure on the stock as investors reevaluated the growth prospects of Hims & Hers Health.

05.07.2025 - HIMS Stock was down 7.3%

• The bearish movement in HIMS stock today can be attributed to several factors:
• A class action lawsuit against Hims & Hers Health, Inc. and its senior executives for potential violations of federal securities laws raised concerns among investors, impacting confidence.
• The company's second-quarter revenue fell short of expectations, leading to a significant drop of over 13% in pre-market trading. This revenue miss likely disappointed investors, triggering a sell-off.
• HIMS also failed to meet Q2 earnings and revenue estimates, further weakening investor sentiment and contributing to the stock's decline.
• The accumulation of negative developments, such as the securities law violations lawsuit and the disappointing financial results, likely fueled the bearish movement in the stock today.

21.07.2025 - HIMS Stock was up 5.9%

• The bullish movement in HIMS stock could be attributed to the company's strategic growth initiatives, such as expanding into new care verticals and international markets.
• The upcoming deadline for lead plaintiff applications in class action lawsuits against Hims & Hers Health, Inc. might have created a sense of urgency among investors to take positions in the stock.
• The launch of new leveraged ETFs by Defiance ETFs, including one for HIMS, could have generated increased interest and trading activity in the stock.
• Despite the ongoing legal investigations and shareholder alerts, investors seem optimistic about the company's long-term growth prospects, leading to the bullish market movement.

30.06.2025 - HIMS Stock was up 9.0%

• Strong product demand and subscriber growth ahead of Q2 earnings are driving HIMS stock higher.
• The bearish trend in Novo Nordisk (NVO) following a warning related to its weight-loss drug Wegovy could be benefiting HIMS as an alternative.
• Despite class action lawsuits and shareholder alerts, HIMS outperformed the broader market, indicating resilience and investor confidence.
• The upcoming deadline for investors to file a Lead Plaintiff Motion with a law firm may have also contributed to the positive momentum in HIMS stock.

26.07.2025 - HIMS Stock was up 5.0%

• Hims & Hers Health, Inc. (NYSE: HIMS) is a company specializing in telehealth and wellness products, addressing various health and personal care needs. The stock showed strong bullish movement today.
• Possible factors like class action lawsuits and short interest could have initially led to uncertainty and volatility in HIMS.
• However, the market sentiment changed as investors possibly identified a short squeeze opportunity, resulting in increased buying pressure and a rise in the stock price.
• The upcoming lead plaintiff deadline and shareholder alerts might have spurred urgency among investors, contributing to the positive momentum in the stock.
• Overall, the blend of short squeeze potential and legal developments likely propelled the bullish movement in HIMS stock today.